Adjuvant chemotherapy for gastric cancer: a randomised phase 3 trial of mitomycin-C plus either short-term doxifluridine or long-term doxifluridine plus cisplatin after curative D2 gastrectomy (AMC0201)

被引：0

作者：

Y-K Kang

H-M Chang

J H Yook

M-H Ryu

I Park

Y J Min

D Y Zang

G Y Kim

D H Yang

S J Jang

Y S Park

J-L Lee

T W Kim

S T Oh

B K Park

H-Y Jung

B S Kim

机构：

[1] Asan Medical Center,Department of Oncology

[2] University of Ulsan College of Medicine,Department of Surgery

[3] 88,Department of Internal Medicine

[4] Olympic-ro 43-gil,Department of Internal Medicine

[5] Songpa-gu,Department of Surgery

[6] Seoul 138-736,Department of Surgery

[7] Korea,Department of Pathology

[8] Asan Medical Center,Departments of Gastroenterology

[9] University of Ulsan College of Medicine,undefined

[10] Ulsan University Hospital,undefined

[11] University of Ulsan College of Medicine,undefined

[12] Hallym University Sacred Heart Hospital,undefined

[13] Hallym University College of Medicine,undefined

[14] Ulsan University Hospital,undefined

[15] University of Ulsan College of Medicine,undefined

[16] Hallym University Sacred Heart Hospital,undefined

[17] Hallym University College of Medicine,undefined

[18] Asan Medical Center,undefined

[19] University of Ulsan College of Medicine,undefined

[20] LSK Global Pharma Services,undefined

[21] Asan Medical Center,undefined

[22] University of Ulsan College of Medicine,undefined

来源：

British Journal of Cancer | 2013年 / 108卷

关键词：

mitomycin-C; doxifluridine; cisplatin; adjuvant chemotherapy; gastric cancer; D2 gastrectomy;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：1245 / 1251

页数：6

共 20 条

[1] Adjuvant chemotherapy for gastric cancer: a randomised phase 3 trial of mitomycin-C plus either short-term doxifluridine or long-term doxifluridine plus cisplatin after curative D2 gastrectomy (AMC0201)
Kang, Y-K
Chang, H-M
Yook, J. H.
Ryu, M-H
Park, I.
Min, Y. J.
Zang, D. Y.
Kim, G. Y.
Yang, D. H.
Jang, S. J.
Park, Y. S.
Lee, J-L
Kim, T. W.
Oh, S. T.
Park, B. K.
Jung, H-Y
Kim, B. S.
BRITISH JOURNAL OF CANCER, 2013, 108 (06) : 1245 - 1251
[2] Three-year outcomes of a phase II study of adjuvant chemotherapy with S-1 plus docetaxel for stage III gastric cancer after curative D2 gastrectomy
Fujitani, Kazumasa
Tamura, Shigeyuki
Kimura, Yutaka
Tsuji, Takeshi
Matsuyama, Jin
Iijima, Shohei
Imamura, Hiroshi
Inoue, Kentaro
Kobayashi, Kenji
Kurokawa, Yukinori
Shimokawa, Toshio
Tsujinaka, Toshimasa
Furukawa, Hiroshi
GASTRIC CANCER, 2014, 17 (02) : 348 - 353
[3] Phase II Feasibility Study of Adjuvant S-1 plus Docetaxel for Stage III Gastric Cancer Patients after Curative D2 Gastrectomy
Tamura, Shigeyuki
Fujitani, Kazumasa
Kimura, Yutaka
Tsuji, Takeshi
Matsuyama, Jin
Iijima, Shohei
Imamura, Hiroshi
Inoue, Kentaro
Kobayashi, Kenji
Kurokawa, Yukinori
Furukawa, Hiroshi
ONCOLOGY, 2011, 80 (5-6) : 296 - 300
[4] Three-year outcomes of a phase II study of adjuvant chemotherapy with S-1 plus docetaxel for stage III gastric cancer after curative D2 gastrectomy
Kazumasa Fujitani
Shigeyuki Tamura
Yutaka Kimura
Takeshi Tsuji
Jin Matsuyama
Shohei Iijima
Hiroshi Imamura
Kentaro Inoue
Kenji Kobayashi
Yukinori Kurokawa
Toshio Shimokawa
Toshimasa Tsujinaka
Hiroshi Furukawa
Gastric Cancer, 2014, 17 : 348 - 353
[5] Survival Outcomes of Two Phase 2 Studies of Adjuvant Chemotherapy with S-1 Plus Oxaliplatin or Capecitabine Plus Oxaliplatin for Patients with Gastric Cancer After D2 Gastrectomy
Nakamura, Yoshiaki
Yamanaka, Takeharu
Chin, Keisho
Cho, Haruhiko
Katai, Hitoshi
Terashima, Masanori
Misawa, Kazunari
Hirao, Motohiro
Yoshida, Kazuhiro
Oki, Eiji
Sasako, Mitsuru
Emi, Yasunori
Bando, Hideaki
Kawashima, Yoshiyuki
Fukunaga, Tetsu
Gotoh, Masahiro
Ishibashi, Takako
Shitara, Kohei
ANNALS OF SURGICAL ONCOLOGY, 2019, 26 (02) : 465 - 472
[6] Survival Outcomes of Two Phase 2 Studies of Adjuvant Chemotherapy with S-1 Plus Oxaliplatin or Capecitabine Plus Oxaliplatin for Patients with Gastric Cancer After D2 Gastrectomy
Yoshiaki Nakamura
Takeharu Yamanaka
Keisho Chin
Haruhiko Cho
Hitoshi Katai
Masanori Terashima
Kazunari Misawa
Motohiro Hirao
Kazuhiro Yoshida
Eiji Oki
Mitsuru Sasako
Yasunori Emi
Hideaki Bando
Yoshiyuki Kawashima
Tetsu Fukunaga
Masahiro Gotoh
Takako Ishibashi
Kohei Shitara
Annals of Surgical Oncology, 2019, 26 : 465 - 472
[7] Phase II study of adjuvant chemotherapy of S-1 plus oxaliplatin for patients with stage III gastric cancer after D2 gastrectomy
Shitara, Kohei
Chin, Keisho
Yoshikawa, Takaki
Katai, Hitoshi
Terashima, Masanori
Ito, Seiji
Hirao, Motohiro
Yoshida, Kazuhiro
Oki, Eiji
Sasako, Mitsuru
Emi, Yasunori
Tsujinaka, Toshimasa
GASTRIC CANCER, 2017, 20 (01) : 175 - 181
[8] Multicenter, Randomized, Phase III Trial of Short-Term Radiotherapy Plus Chemotherapy Versus Long-Term Chemoradiotherapy in Locally Advanced Rectal Cancer (STELLAR)
Jin, Jing
Tang, Yuan
Hu, Chen
Jiang, Li-Ming
Jiang, Jun
Li, Ning
Liu, Wen-Yang
Chen, Si-Lin
Li, Shuai
Lu, Ning-Ning
Cai, Yong
Li, Yong-Heng
Zhu, Yuan
Cheng, Guang-Hui
Zhang, Hong-Yan
Wang, Xin
Zhu, Su-Yu
Wang, Jun
Li, Gao-Feng
Yang, Jia-Lin
Zhang, Kuan
Chi, Yihebali
Yang, Lin
Zhou, Hai-Tao
Zhou, Ai-Ping
Zou, Shuang-Mei
Fang, Hui
Wang, Shu-Lian
Zhang, Hai-Zeng
Wang, Xi-Shan
Wei, Li-Chun
Wang, Wen-Ling
Liu, Shi-Xin
Gao, Yuan-Hong
Li, Ye-Xiong
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (15) : 1681 - +
[9] Five-year outcomes of a phase II study of adjuvant chemotherapy with S-1 plus docetaxel for stage III gastric cancer after curative D2 gastrectomy (OGSG1002)
Fujitani, Kazumasa
Tamura, Shigeyuki
Kimura, Yutaka
Matsuyama, Jin
Imamura, Hiroshi
Yamamoto, Kazuyoshi
Fujita, Junya
Iijima, Shohei
Ueda, Shugo
Kurokawa, Yukinori
Shimokawa, Toshio
Satoh, Taroh
GASTRIC CANCER, 2020, 23 (03) : 520 - 530
[10] Phase II study of adjuvant chemotherapy of S-1 plus oxaliplatin for patients with stage III gastric cancer after D2 gastrectomy
Kohei Shitara
Keisho Chin
Takaki Yoshikawa
Hitoshi Katai
Masanori Terashima
Seiji Ito
Motohiro Hirao
Kazuhiro Yoshida
Eiji Oki
Mitsuru Sasako
Yasunori Emi
Toshimasa Tsujinaka
Gastric Cancer, 2017, 20 : 175 - 181

← 1 2 →